Literature DB >> 29732714

Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans.

Pravitt Gourh1, Elaine F Remmers2, Steven E Boyden2, Theresa Alexander3, Nadia D Morgan4, Ami A Shah4, Maureen D Mayes5, Ayo Doumatey2, Amy R Bentley2, Daniel Shriner2, Robyn T Domsic6, Thomas A Medsger6, Virginia D Steen7, Paula S Ramos8, Richard M Silver8, Benjamin Korman9, John Varga9, Elena Schiopu10, Dinesh Khanna10, Vivien Hsu11, Jessica K Gordon12, Lesley Ann Saketkoo13, Heather Gladue14, Brynn Kron15, Lindsey A Criswell15, Chris T Derk16, S Louis Bridges17, Victoria K Shanmugam18, Kathleen D Kolstad19, Lorinda Chung20, Reem Jan21, Elana J Bernstein22, Avram Goldberg23, Marcin Trojanowski24, Suzanne Kafaja25, Kathleen M Maksimowicz-McKinnon26, James C Mullikin27, Adebowale Adeyemo2, Charles Rotimi2, Francesco Boin15, Daniel L Kastner2, Fredrick M Wigley4.   

Abstract

OBJECTIVE: Whole-exome sequencing (WES) studies in systemic sclerosis (SSc) patients of European American (EA) ancestry have identified variants in the ATP8B4 gene and enrichment of variants in genes in the extracellular matrix (ECM)-related pathway that increase SSc susceptibility. This study was undertaken to evaluate the association of the ATP8B4 gene and the ECM-related pathway with SSc in a cohort of African American (AA) patients.
METHODS: SSc patients of AA ancestry were enrolled from 23 academic centers across the US under the Genome Research in African American Scleroderma Patients consortium. Unrelated AA individuals without serologic evidence of autoimmunity who were enrolled in the Howard University Family Study were used as unaffected controls. Functional variants in genes reported in the 2 WES studies in EA patients with SSc were selected for gene association testing using the optimized sequence kernel association test (SKAT-O) and pathway analysis by Ingenuity Pathway Analysis in 379 patients and 411 controls.
RESULTS: Principal components analysis demonstrated that the patients and controls had similar ancestral backgrounds, with roughly equal proportions of mean European admixture. Using SKAT-O, we examined the association of individual genes that were previously reported in EA patients and none remained significant, including ATP8B4 (P = 0.98). However, we confirmed the previously reported association of the ECM-related pathway with enrichment of variants within the COL13A1, COL18A1, COL22A1, COL4A3, COL4A4, COL5A2, PROK1, and SERPINE1 genes (corrected P = 1.95 × 10-4 ).
CONCLUSION: In the largest genetic study in AA patients with SSc to date, our findings corroborate the role of functional variants that aggregate in a fibrotic pathway and increase SSc susceptibility.
© 2018, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29732714      PMCID: PMC6160338          DOI: 10.1002/art.40541

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  15 in total

1.  Identification of Rare Variants in ATP8B4 as a Risk Factor for Systemic Sclerosis by Whole-Exome Sequencing.

Authors:  Li Gao; Mary J Emond; Tin Louie; Chris Cheadle; Alan E Berger; Nicholas Rafaels; Candelaria Vergara; Yoonhee Kim; Margaret A Taub; Ingo Ruczinski; Stephen C Mathai; Stephen S Rich; Deborah A Nickerson; Laura K Hummers; Michael J Bamshad; Paul M Hassoun; Rasika A Mathias; Kathleen C Barnes
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

2.  Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.

Authors:  Timothy R D J Radstake; Olga Gorlova; Blanca Rueda; Jose-Ezequiel Martin; Behrooz Z Alizadeh; Rogelio Palomino-Morales; Marieke J Coenen; Madelon C Vonk; Alexandre E Voskuyl; Annemie J Schuerwegh; Jasper C Broen; Piet L C M van Riel; Ruben van 't Slot; Annet Italiaander; Roel A Ophoff; Gabriela Riemekasten; Nico Hunzelmann; Carmen P Simeon; Norberto Ortego-Centeno; Miguel A González-Gay; María F González-Escribano; Paolo Airo; Jaap van Laar; Ariane Herrick; Jane Worthington; Roger Hesselstrand; Vanessa Smith; Filip de Keyser; Fredric Houssiau; Meng May Chee; Rajan Madhok; Paul Shiels; Rene Westhovens; Alexander Kreuter; Hans Kiener; Elfride de Baere; Torsten Witte; Leonid Padykov; Lars Klareskog; Lorenzo Beretta; Rafaella Scorza; Benedicte A Lie; Anna-Maria Hoffmann-Vold; Patricia Carreira; John Varga; Monique Hinchcliff; Peter K Gregersen; Annette T Lee; Jun Ying; Younghun Han; Shih-Feng Weng; Christopher I Amos; Fredrick M Wigley; Laura Hummers; J Lee Nelson; Sandeep K Agarwal; Shervin Assassi; Pravitt Gourh; Filemon K Tan; Bobby P C Koeleman; Frank C Arnett; Javier Martin; Maureen D Mayes
Journal:  Nat Genet       Date:  2010-04-11       Impact factor: 38.330

3.  Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts.

Authors:  F C Arnett; M Cho; S Chatterjee; M B Aguilar; J D Reveille; M D Mayes
Journal:  Arthritis Rheum       Date:  2001-06

Review 4.  Ethnogenetic heterogeneity of rheumatoid arthritis-implications for pathogenesis.

Authors:  Yuta Kochi; Akari Suzuki; Ryo Yamada; Kazuhiko Yamamoto
Journal:  Nat Rev Rheumatol       Date:  2010-03-16       Impact factor: 20.543

5.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

6.  Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.

Authors:  Frank C Arnett; Pravitt Gourh; Sanjay Shete; Chul W Ahn; Robert E Honey; Sandeep K Agarwal; Filemon K Tan; Terry McNearney; Michael Fischbach; Marvin J Fritzler; Maureen D Mayes; John D Reveille
Journal:  Ann Rheum Dis       Date:  2009-07-12       Impact factor: 19.103

7.  Brief Report: Whole-Exome Sequencing for Identification of Potential Causal Variants for Diffuse Cutaneous Systemic Sclerosis.

Authors:  Angel C Y Mak; Paul L F Tang; Clare Cleveland; Melanie H Smith; M Kari Connolly; Tamiko R Katsumoto; Paul J Wolters; Pui-Yan Kwok; Lindsey A Criswell
Journal:  Arthritis Rheumatol       Date:  2016-09       Impact factor: 10.995

8.  Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.

Authors:  Maureen D Mayes; James V Lacey; Jennifer Beebe-Dimmer; Brenda W Gillespie; Brenda Cooper; Timothy J Laing; David Schottenfeld
Journal:  Arthritis Rheum       Date:  2003-08

9.  A genome-wide association study of hypertension and blood pressure in African Americans.

Authors:  Adebowale Adeyemo; Norman Gerry; Guanjie Chen; Alan Herbert; Ayo Doumatey; Hanxia Huang; Jie Zhou; Kerrie Lashley; Yuanxiu Chen; Michael Christman; Charles Rotimi
Journal:  PLoS Genet       Date:  2009-07-17       Impact factor: 5.917

10.  Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.

Authors:  Nadia D Morgan; Ami A Shah; Maureen D Mayes; Robyn T Domsic; Thomas A Medsger; Virginia D Steen; John Varga; Mary Carns; Paula S Ramos; Richard M Silver; Elena Schiopu; Dinesh Khanna; Vivien Hsu; Jessica K Gordon; Heather Gladue; Lesley A Saketkoo; Lindsey A Criswell; Chris T Derk; Marcin A Trojanowski; Victoria K Shanmugam; Lorinda Chung; Antonia Valenzuela; Reem Jan; Avram Goldberg; Elaine F Remmers; Daniel L Kastner; Fredrick M Wigley; Pravitt Gourh; Francesco Boin
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more
  4 in total

Review 1.  The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview.

Authors:  Bianca Saveria Fioretto; Irene Rosa; Eloisa Romano; Yukai Wang; Serena Guiducci; Guohong Zhang; Mirko Manetti; Marco Matucci-Cerinic
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-05-06       Impact factor: 5.346

2.  HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry.

Authors:  Pravitt Gourh; Sarah A Safran; Theresa Alexander; Steven E Boyden; Nadia D Morgan; Ami A Shah; Maureen D Mayes; Ayo Doumatey; Amy R Bentley; Daniel Shriner; Robyn T Domsic; Thomas A Medsger; Paula S Ramos; Richard M Silver; Virginia D Steen; John Varga; Vivien Hsu; Lesley Ann Saketkoo; Elena Schiopu; Dinesh Khanna; Jessica K Gordon; Brynn Kron; Lindsey A Criswell; Heather Gladue; Chris T Derk; Elana J Bernstein; S Louis Bridges; Victoria K Shanmugam; Kathleen D Kolstad; Lorinda Chung; Suzanne Kafaja; Reem Jan; Marcin Trojanowski; Avram Goldberg; Benjamin D Korman; Peter J Steinbach; Settara C Chandrasekharappa; James C Mullikin; Adebowale Adeyemo; Charles Rotimi; Fredrick M Wigley; Daniel L Kastner; Francesco Boin; Elaine F Remmers
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

3.  Elucidating the cellular mechanism for E2-induced dermal fibrosis.

Authors:  DeAnna Baker Frost; Alisa Savchenko; Adeyemi Ogunleye; Milton Armstrong; Carol Feghali-Bostwick
Journal:  Arthritis Res Ther       Date:  2021-02-27       Impact factor: 5.156

4.  Pathogenesis of systemic sclerosis associated interstitial lung disease.

Authors:  Svetlana I Nihtyanova; Christopher P Denton
Journal:  J Scleroderma Relat Disord       Date:  2020-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.